Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the 'New Drug Re-examination'.
Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the "New Drug Re-examination".
NCT ID: NCT02489331 Phase: Status: COMPLETED Enrollment: 193 Completion: 2020-11-10
Conditions
Dyslipidemias
Summary
Post marketing surveillance of safety and efficacy for Cholib in Korean patients under the "New Drug Re-examination"
Primary Outcome
Incidence of adverse event after Cholib administration in general medical practice